Marco Montagna
-
- Platelet Disorders and Treatments 1
-
- Chronic Lymphocytic Leukemia Research 2
-
- Retinal and Optic Conditions 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- HIV Research and Treatment 1
-
- Virology and Viral Diseases 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 1
-
- Drug-Induced Adverse Reactions 1
- Co-authors
- Mario RegazziMaria Antonietta AvanziniMichele BaccaraniFrancesco BandelloMiriam IsolaM. IppolitiMarzia DefinaFrancesco Romano
- Cited by
- HematologyGeneticsNephrology
- Partner nations
- ItalyJapanUnited Kingdom
In The Last Decade
Marco Montagna
12 papers receiving 162 citations
Peers
Comparison fields: 5 of 50
- Hematology 64
- Genetics 39
- Nephrology 20
- Pathology and Forensic Medicine 38
- Ophthalmology 17
Countries citing papers authored by Marco Montagna
This map shows the geographic impact of Marco Montagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Montagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Montagna more than expected).
Fields of papers citing papers by Marco Montagna
This network shows the impact of papers produced by Marco Montagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Montagna. The network helps show where Marco Montagna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marco Montagna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 6 | |
| 7 | 2018 | 8 | |
| 8 | 2017 | 10 | |
| 9 | Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features. | 2015 | 30 |
| 10 | 2011 | 18 | |
| 11 | 2008 | 78 | |
| 12 | 2007 | 7 | |
| 13 | 2001 | 6 |
About Marco Montagna
Marco Montagna is a scholar working on Health Informatics, Critical Care and Intensive Care Medicine and Ophthalmology, having authored 13 papers that have together received 170 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Retinal and Optic Conditions (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HIV Research and Treatment (1 paper), Virology and Viral Diseases (1 paper), Platelet Disorders and Treatments (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Drug-Induced Adverse Reactions (1 paper). The work is most often cited by research in Hematology (64 citations), Genetics (39 citations) and Nephrology (20 citations). Marco Montagna has collaborated with scholars based in Italy, Japan and United Kingdom. Frequent co-authors include Mario Regazzi, Maria Antonietta Avanzini, Michele Baccarani, Francesco Bandello, Miriam Isola, M. Ippoliti, Marzia Defina, Francesco Romano, Renato Fanin and Monica Bocchia. Their work appears in journals such as Haematologica, Medicine, Frontiers in Medicine, JMIR Medical Education and Journal of Medical Internet Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.